Archean Chemical Industries Limited has informed the Exchange about Investor Presentation
ACI · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Archean Chemical Industries reported Q1 FY26 standalone revenue of Rs 2,914.5 million, up 30% year-on-year, driven by a steady product mix with exports contributing about 81% of operating revenue. Standalone EBITDA rose to Rs 958 million and profit after tax increased to Rs 518.5 million (EPS Rs 4.20 vs Rs 3.23). The Bromine business showed steady growth with limited price volatility impact due to long-term bilateral contracts, while Industrial Salt remained stable. On the strategic front, the company is expanding into new areas: 3 units of Idealis Chemicals (acquired via NCLT in July 2024) are under trials, a GBP 12.5 million investment in UK-based Clas-Sic Wafer Fab (22.24% stake) is complete to secure exclusive SiC semiconductor technology in India, and an 18.14% stake in US-based Offgrid Energy Labs has been secured for $12 million to enter the Zinc Bromide battery and energy storage market.
Strong 30% revenue growth and stable margins suggest healthy core operations. However, the company is making large strategic bets into semiconductors and energy storage, which are far removed from its core marine chemicals business and carry execution risk. Shareholders should watch for trial outcomes at Idealis Chemicals, government approval for the SiCSem plant, and scaling of bromine derivatives.